共 9 条
[1]
Hutchins L,Green S,Ravdin P,et al.CMF versus CAF with and without tamoxifen in high risk node negative breast cancer patients and a natural history follow-up study in low risk node negative patients: first results of Intergroup trial in 0102. Proceedings of the American Society of Clinical Oncology . 1998
[2]
Goss PE,Ingle JN,Martino S,et al.Random ized placebo-controlled trial of letrozole in postmenopausal women with early breast cancer completing five years of tamoxifen. BreastCancer Res Treat, 2003, 82 (Supple 1 ): abstr .
[3]
Mamounas EP,Bryant J,Lembersky BC,et al.paclitaxel (T)following doxorubicin /cyclophospham ide ( AC ) as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28. Proceedings of the American Society of Clinical Oncology . 2003
[4]
Henderson IC,Berry DA,Demetri GD,et al.Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. Journal of Clinical Oncology . 2003
[5]
Bonadonna G,Brusamolion E,Valagussa P,et al.Combination chemotherapy as an adjuvant treatment in operable breast cancer. The New England Journal of Medicine . 1976
[6]
C itron ML,Berry DA,C irrincione C,et al.Random ized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer; first report of intergroup trail C9741 /Cancer and leukem. Journal of Clinical Oncology . 2003
[7]
Baum M,BudzarAU,Cuzick J,et al.Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausalwomen with early breast cancer: first results of the ATAC random ized trial. The Lancet . 2002
[8]
Coombes RC,Hall E,G ibson LJ,et al.A random ized trial of exmestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. The New England Journal of Medicine . 2004
[9]
Bonadonna G,Valagussa PM,O litem i A,et al.Adjuvant cyclophosham ide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. The New England Journal of Medicine . 1995